The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,332.00
Bid: 11,500.00
Ask: 12,400.00
Change: 0.00 (0.00%)
Spread: 900.00 (7.826%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EC chief warns Astra must honour contract before exporting doses

Fri, 26th Mar 2021 05:59

(Alliance News) - The European Commission president has warned AstraZeneca PLC that it must "honour" its vaccine contract with the bloc before exporting doses elsewhere in the world.

Ursula von der Leyen urged "transparency" from other countries, but did not confirm if the EU would bring in tougher export restrictions on coronavirus jabs, amid a row over supplies with the British-Swedish pharmaceutical giant.

However, she acknowledged that worldwide supply chains needed to remain "intact" for vaccine production, while some European leaders appeared optimistic that the UK and EU could soon resolve their dispute over supplies.

Elsewhere, UK Prime Minister Boris Johnson sought to calm fears over the possible introduction of coronavirus certificates after publicans criticised his suggestion that it may be up to landlords to decide to request proof of vaccination in venues.

Just days after the prime minister flagged tougher measures to prevent Covid-19 variants being transmitted from Europe, the Telegraph reports the government is planning to implement a mass testing regime for lorry drivers arriving in the UK.

Earlier, addressing a Brussels press conference following a meeting of the European Council on Thursday, von der Leyen said she had "no knowledge" of the UK exporting jabs, while 77 million doses had been exported to 33 countries by the EU so far.

It came after the European Commission set out a tougher regime to stem supplies of jabs to nations faring better in the pandemic as the bloc's states faced a third wave of cases.

von der Leyen told reporters: "Companies have to honour their contract to the EU before they export to other regions in the world. This is of course the case with AstraZeneca.

"I think it is clear that the company [AstraZeneca] has to catch up and honour the contract it has with the EU member states before it can engage again in exporting vaccines."

She added: "We have worldwide supply chains that have to be intact and it is of the utmost importance that we get back to an attitude of openness."

Asked about how many vaccines the UK had exported, von der Leyen told reporters: "I have no knowledge so far of UK exports, perhaps I am mistaken and waiting for their transparency."

Following the summit, Belgian Prime Minister Alexander de Croo said that he believed the EU's dispute with the UK over vaccine supplies "can be resolved" as he referred to a phone call with Johnson last week.

"We think that the discussion we have with the UK can be resolved based on good agreements," de Croo told a Brussels press conference.

Striking a similar tone, Dutch Prime Minister Mark Rutte said that he was "cautiously optimistic" that divisions between the UK and the EU could be resolved.

"I think that on Saturday or soon after, they could come to an agreement which would be very helpful because we are friends, the UK and the rest of Europe, and we need each other," he told reporters.

But leaders appeared to be divided on the issue following the summit, with French president Emmanuel Macron insisting that the EU is "no longer naive" with its export controls tool.

It came after Johnson acknowledged the "moral complexities" around a domestic coronavirus certificate and suggested that it might only be possible to introduce one after all adults had been offered a vaccine at the end of July.

The government will say more on the possible use of Covid status certificates in early April, which could be based on whether people have developed antibodies through infection, as well as vaccinations and negative tests.

But landlords rejected their use after the PM's earlier suggestion it could be up to them to decide whether to screen customers' certificates on entry.

A mobile phone app which features a scannable QR code could be used to provide a virtual coronavirus certificate for entrance into pubs, clubs and restaurants, according to the Daily Mail.

Measures to implement Johnson's "road map" out of lockdown, which will see England's restrictions eased in a series of stages over the coming months, were passed without a vote.

But a series of Tory MPs refused to back a six-month extension to emergency powers contained in the Coronavirus Act after Health Secretary Matt Hancock was unable to say whether they would definitely expire after that.

Some 76 MPs voted to oppose the extension of the laws, although the measure passed with a majority of 408.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.